Evidence map›Paper›PMID 37546546›Full record

ArticleJAC-antimicrobial resistance2023

The epidemiology and microbiological characteristics of infections caused by Gram-negative bacteria in Qatar: national surveillance from the Study for Monitoring of Antimicrobial Resistance Trends (SMART): 2017 to 2019.

Mazen A Sid Ahmed, Hawabibee Mahir Petkar, Thoraya M Saleh, Mohamed Albirair, Lolita A Arisgado, Faiha K Eltayeb, Manal Mahmoud Hamed, Muna A Al-Maslamani, Abdul Latif Al Khal, Hussam Alsoub and 2 more

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Microbiology spectrum · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mazen A Sid AhmedPhiladelphia Department of Public Health, Laboratory Services, Philadelphia, USA.
Hawabibee Mahir PetkarDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Thoraya M SalehDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Mohamed AlbirairDepartment of Global Health, University of Washington, Seattle, USA.
Lolita A ArisgadoDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Faiha K EltayebDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Manal Mahmoud HamedDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Muna A Al-MaslamaniDivision of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar.
Abdul Latif Al KhalDivision of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar.
Hussam AlsoubDivision of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar.
Emad Bashir IbrahimDivision of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Hamad Abdel HadiDivision of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0001-8647-1695

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global Study of Monitoring Antimicrobial Resistance Trends (SMART) is a surveillance program for evaluation of antimicrobial resistance (AMR) in Gram-negative bacteria (GNB) from different regions including Gulf countries. Objectives: To evaluate AMR in GNB from various clinical specimens including microbiological and genetic characteristics for existing and novel antimicrobials. Methods: A prospective study was conducted on clinical specimens from Hamad Medical Corporation, Qatar, between 2017 and 2019 according to the SMART protocol. Consecutive GNB from different sites were evaluated including lower respiratory, urinary tract, intrabdominal and bloodstream infections. Results: Over the 3 years study period, 748 isolates were evaluated from the specified sites comprising 37 different GNB outlining four key pathogens: Conclusions: Surveillance of GNB from Qatar showed prevalence of key pathogens similar to other regions but demonstrated significant resistance patterns to existing and novel antimicrobials with different underlying resistance mechanisms.

Identifiers

PMID37546546
PMCPMC10400155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.